TABLE 2

Pharmacokinetics of midazolam (MDZ) in wild-type and PXR-humanized mice pretreated with or without rifampicin (RIF) at 10 mg/kg/day for 3 days Serum MDZ was detected by liquid chromatography-mass spectrometry/mass spectrometry. Pharmacokinetic parameters were estimated from the serum concentration-time (three mice at each time point) data by a noncompartmental approach using WinNonlin. Data are expressed as means ± S.D.


Genotype

MDZ

Control

RIF

RIF
% control
Wild-type Cmax (nM) 1090 ± 50 908 ± 3 83.6
AUC0–180 (nmol · min/l) 55,300 ± 5200 50,200 ± 2900 90.7
hPXR Cmax (nM) 748 ± 45 266 ± 7* 35.6

AUC0–180 (nmol · min/l)
38,000 ± 3000
14,800 ± 493**
40.0
  • * P < 0.0001 compared to control

  • ** P = 0.0002 compared to control